Cardiomyopathies Flashcards
3 Main categories
- Dilated (MC)
- Hypertrophic (HT CM #1 cause sudden death athletes)
- Restrictive
Dilated pathophysiology
Dilated ventricles, no hypertrophy.
Systolic failure, EDV & ESV increase, LVEF decreases.
Dilation worsens due to increased volume blood.
May cause mitral/tricuspid regurgitation-worsens CO.
S/s due to back up of blood or decreased CO.
Dilated causes
Alcohol Beriberi Coxsackie B/Chagas Drugs Pregnancy Idiopathic (50%)/Infection Genetic
Interstitial/Endocardial fibrosis
Ischemic dilated CM
MCC of dilated CM.
MCC of systolic HF.
LVEF<35-40% from CAD.
Tx: same + CAD tx
HTN dilated CM
Concentric LVH–Dilation–Eccentric remodeling
With Systolic dysfunction
Alcoholic dilated CM
Mechanism: unclear, Acetaldehyde–myocardial depression
>90g (7-8 drinks) for >5 years
Increased QTc due to decreased Mg/K
Tx: Abstinence, will improve outcome.
Peripartum dilated CM
When? Late preg (after 36 wks) & w/in 5 mo of birth
Risk factors: AA, >30yo, Cocaine, Multiple fetus, Ecclampsia/Pre.
Tx: transplant 1/3. If LVEF >50% 6mo., can wean off tx.
Mortality: 10% in 2 years.
Takotsubo dilated CM
Transient decreased LVEF
Systolic apical ballooning on echo (hyperkinesis in upper walls, apex balloons)
Sx: CP, Trop increased, ST elevation. NO CAD.
Cause: stress, catelcholamines, post-menopausal
Recovery: 1-4 weeks, increased risk for arrhythmia/shock.
Recurrence: beta-blockers
Dilated CM clinical presentation
Age 20-60, but any age
HF sx: dyspnea, JVD, peripheral edema, congestive cough with white sputum.
Misdx: Viral URI in younger population.
Hx: Breast cancer chemo, thyroid, drug use, family hx of sudden cardiac death.
Dilated CM PE signs
- HF signs (Hepatojug reflux/JVD/crackles/clubbing)
- PMI shifted left
- S3 gallop
Dilated CM Dx test
- Labs: CBC (anemia), CMP (hyponatremia=poor prognosis), Thyroid, Biomarkers/BNP, Urine drug if suspicious
- CXR: cardiomegaly, Kerley B, R pleural effusion, congestion
- EKG: LVH, arrhythmias, conduction delay
- Cath: R/O ischemic cause
- Biopsy: limited use, for amyloid/sarcoid
Dilated CM medical tx
- ACE/ARB + Diuretic/Aldosterone ant. + Beta-blocker
- ARNI
- Inotropes for end-stage
- Anticoag for AFib
- Nitrates for sx relief
- Revascularize if ischemic
Dilated CM surgical tx
- LVAD
- CRT (resynchronization): LVEF<35, BBB, pers HF sx
- AICD (cardiovert/defib): At risk for ventricular arrhythmias
- Transplant: Dilated CM=45% of transplants in US
Hypertrophic CM etiology
1. Familial HCM (50-60%) Genetic, Autosomal dominant mutation of sarcomere 2. Septum abnormalities 3. Subendocardial ischemia 4. Abnormal SNS 5. Ab thick intramural coronary aa.
Hypertrophic CM epidemiology
0.5% population (1/200 adults)
M>F, F present younger
MC in 3rd decade